Refractory Chronic Lymphocytic Leukemia: Clinical Trials

3 trials for Refractory Chronic Lymphocytic Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3

Follow Refractory Chronic Lymphocytic Leukemia: new trials by email Literature Review of Refractory Chronic Lymphocytic Leukemia trials Research Report on Refractory Chronic Lymphocytic Leukemia

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
Allogeneic Hematopoietic Stem Cell Transplantation, Cyclosporine, Fludarabine Phosphate - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 3CompletedFred Hutchinson Cancer Center1742010-11-012026-04-30
Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications
internet-based intervention, questionnaire administration, psychosocial assessment and care - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 3CompletedFred Hutchinson Cancer Research Center/University of Washington Cancer Consortium13372008-08-012012-03-07
Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
Total-Body Irradiation, Fludarabine Phosphate, Mycophenolate Mofetil - Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission
Phase 3CompletedFred Hutchinson Cancer Center872003-10-012017-05-15

Narrower conditions

Hodgkin Disease (3)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (3)  ·  Lymphoma, Large B-Cell, Diffuse (3)  ·  Lymphoma, Mantle-Cell (3)  ·  Multiple Myeloma (3)  ·  Hematologic Neoplasms (2)  ·  Leukemia, Myeloid, Acute (2)  ·  Leukemia, Myeloid, Chronic-Phase (2)  ·  Myeloproliferative Disorders (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Waldenstrom Macroglobulinemia (2)  ·  Blast Crisis (1)  ·  Burkitt Lymphoma (1)  ·  Congenital Abnormalities (1)  ·  Depression (1)

Broader conditions

Blood Protein Disorders (3)  ·  Bone Marrow Diseases (3)  ·  Cardiovascular Diseases (3)  ·  Chronic Disease (3)  ·  Disease Attributes (3)  ·  Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Hemorrhagic Disorders (3)  ·  Hemostatic Disorders (3)  ·  Immune System Diseases (3)  ·  Immunoproliferative Disorders (3)  ·  Leukemia (3)  ·  Leukemia, B-Cell (3)  ·  Leukemia, Lymphoid (3)  ·  Leukemia, Myeloid (3)

Interventions

Cyclosporine (2)  ·  Cyclosporins (2)  ·  Mycophenolic Acid (2)  ·  Peripheral Blood Stem Cell Transplantation (2)  ·  Whole-Body Irradiation (2)  ·  fludarabine phosphate (2)  ·  Counseling (1)  ·  Psychiatric Rehabilitation (1)  ·  Sirolimus (1)  ·  Therapeutics (1)

Sponsors

Fred Hutchinson Cancer Center (2)  ·  Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium (1)

Countries

United States (3)  ·  Germany (2)  ·  Denmark (1)  ·  Italy (1)

Top investigators

Brenda Sandmaier (2)  ·  Karen Syrjala (1)

Results publications

PMID 32499241, PMID 31248843, PMID 32628342, PMID 33420905, PMID 36282798

NIH funding

P30CA015704 (2), P01CA018029 (1), P01CA078902 (1), R01CA112631 (1)